loading...| Preferred Name | Indinavir Anhydrous | |
| Synonyms |
|
|
| Definitions |
An anhydrous formulation of indinavir, a synthetic hydroxyaminopentane amide agent that selectively inhibits the protease of both human immunodeficiency virus 1 and 2. The incorporation of a basic amine into the hydroxyethylene backbone improves its aqueous solubility and its oral bioavailability. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C74585 |
|
| CAS_Registry |
150378-17-9 |
|
| CHEBI_ID |
CHEBI:44032 |
|
| Chemical_Formula |
C36H47N5O4 |
|
| code |
C74585 |
|
| Contributing_Source |
FDA |
|
| definition |
An anhydrous formulation of indinavir, a synthetic hydroxyaminopentane amide agent that selectively inhibits the protease of both human immunodeficiency virus 1 and 2. The incorporation of a basic amine into the hydroxyethylene backbone improves its aqueous solubility and its oral bioavailability. |
|
| FDA_UNII_Code |
9MG78X43ZT |
|
| in_subset | ||
| label |
Indinavir Anhydrous |
|
| Legacy Concept Name |
Indinavir_Anhydrous |
|
| Preferred_Name |
Indinavir Anhydrous |
|
| prefixIRI |
NCIT:C74585 |
|
| prefLabel |
Indinavir Anhydrous |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C2697674 |
|
| subClassOf |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C74585 | NCIT | LOOM | |
| http://purl.bioontology.org/ontology/RXNORM/1546024 | RXNORM | LOOM |